AMI Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$530K Sell
8,197
-465
-5% -$32.8K 0.03% 75
2025
Q4
$583K Sell
8,662
-3,423
-28% -$230K 0.03% 75
2025
Q3
$886K Sell
12,085
-7,591
-39% -$504K 0.05% 65
2025
Q2
$1.02M Sell
19,676
-16,475
-46% -$937K 0.06% 52
2025
Q1
$2.31M Sell
36,151
-1,309
-3% -$76K 0.14% 44
2024
Q4
$1.79M Sell
37,460
-11,484
-23% -$589K 0.1% 45
2024
Q3
$2.8M Sell
48,944
-7,702
-14% -$442K 0.15% 37
2024
Q2
$2.97M Sell
56,646
-80,744
-59% -$3.54M 0.16% 36
2024
Q1
$5.59M Sell
137,390
-5,665
-4% -$212K 0.29% 35
2023
Q4
$5.29M Sell
143,055
-5,183
-3% -$195K 0.29% 37
2023
Q3
$5.66M Sell
148,238
-3,508
-2% -$144K 0.35% 33
2023
Q2
$5.47M Buy
151,746
+6,226
+4% +$212K 0.33% 32
2023
Q1
$5.56M Buy
145,520
+19,938
+16% +$935K 0.35% 31
2022
Q4
$7.15M Sell
125,582
-37
-0% -$1.89K 0.5% 32
2022
Q3
$4.97M Sell
125,619
-69,772
-36% -$3.08M 0.36% 36
2022
Q2
$8.6M Sell
195,391
-53,070
-21% -$2.3M 0.55% 34
2022
Q1
$9.91M Buy
248,461
+12,160
+5% +$433K 0.52% 35
2021
Q4
$9.5M Sell
236,301
-22,646
-9% -$845K 0.46% 38
2021
Q3
$10.5M Buy
258,947
+8,977
+4% +$375K 0.53% 38
2021
Q2
$11.4M Buy
249,970
+3,395
+1% +$150K 0.57% 36
2021
Q1
$10.3M Buy
246,575
+1,099
+0.4% +$50.2K 0.54% 36
2020
Q4
$10.5M Sell
245,476
-272,050
-53% -$9.78M 0.52% 36
2020
Q3
$13.6M Sell
517,526
-8,863
-2% -$247K 0.69% 35
2020
Q2
$14.1M Buy
+526,389
New +$11.9M 0.75% 33

Other funds holding HALO

AMI Asset Management's HALO Position: Q1 2026 in Review

AMI Asset Management reduced its Halozyme (HALO) stake by 5.4% in Q1 2026, selling an estimated $32.8K and leaving 8,197 shares worth $530K. The position accounts for 0.03% of the portfolio, ranked #75.

AMI Asset Management first reported a position in HALO in Q2 2020 and has held it in 24 quarters since. The position peaked at $14.1M in Q2 2020. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • AMI Asset Management held 8,197 shares of Halozyme worth $530K as of Q1 2026.
  • AMI Asset Management sold 465 Halozyme shares in Q1 2026, an estimated $32.8K.
  • Halozyme made up 0.03% of AMI Asset Management's portfolio in Q1 2026, its #75 holding.
  • AMI Asset Management first reported a position in Halozyme in Q2 2020 and has held it in 24 quarters since.
  • AMI Asset Management's Halozyme position peaked at $14.1M in Q2 2020.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on AMI Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.